Empaglifozin
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production (NCT03852901) | National Institute on Aging (NIA) | 2019-03-28 |
Track Empaglifozin automatically
Every clearance here is in the API, with alerts when new ones post.